Asia Pacific Stem Cell Manufacturing Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2021 –2028 |
 Tamanho do mercado (ano base ) | USD 11,076.78 Million |
 Tamanho do mercado ( Ano de previsão) | USD 23,505.08 Million |
 CAGR |
% |
| Principais participantes do mercado |
Mercado de fabrico de células estaminais Ásia-Pacífico, por produtos (linhas de células estaminais, instrumentos, consumíveis e kits), aplicação (aplicações de investigação, aplicações clínicas, bancos de células e tecidos e outros), utilizador final (empresas de biotecnologia e farmacêuticas, institutos de investigação e académicos Institutos, bancos de células e bancos de tecidos, centros hospitalares e cirúrgicos e outros), canal de distribuição (venda direta e distribuidor terceirizado), país (Japão, China, Austrália, Coreia do Sul, Índia, Singapura, Tailândia, Indonésia, Malásia, Filipinas e Resto da Ásia-Pacífico). Tendências e previsões da indústria para 2028.
Análise e insights de mercado: Mercado de fabrico de células estaminais Ásia-Pacífico
Espera-se que o mercado de fabrico de células estaminais da Ásia-Pacífico ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 10,1% no período de previsão de 2021 a 2028 e prevê-se que atinja os 23.505,08 milhões de dólares até 2028, contra os 11.076,78 milhões de dólares em 2020. A crescente prevalência de cancro e transplante de células estaminais, o crescimento de novos avanços tecnológicos para transplante de células estaminais serão provavelmente os principais impulsionadores que impulsionam a procura do mercado no período de previsão .
As células estaminais são a matéria-prima do corpo que se pode diferenciar numa variedade de células. Significa células a partir das quais são geradas todas as outras células com funções especializadas. As terapias com células estaminais são definidas como tratamento para condições médicas que envolvem a utilização de qualquer tipo de células estaminais humanas , incluindo células estaminais embrionárias, células estaminais adultas para terapias alogénicas e autólogas.
O advento da investigação com células estaminais revelou o potencial terapêutico das células estaminais e derivados . O fabrico bem-sucedido de células estaminais e seus derivados está a causar um impacto positivo na área da saúde. Estes produtos de células estaminais são utilizados para restaurar a função de tecidos e órgãos danificados e para desenvolver terapias celulares baseadas em células estaminais para o tratamento de cancro, distúrbios hematológicos, distúrbios genéticos , doenças autoimunes e inflamatórias.
O aumento da investigação e desenvolvimento por parte dos principais intervenientes da indústria para o desenvolvimento de produtos inovadores, o apoio governamental e a crescente adopção de células estaminais estão a impulsionar o crescimento do mercado. As metodologias avançadas presentes na área estão também a impulsionar o crescimento do mercado global de fabrico de células estaminais. No entanto, o elevado custo das terapias e a disponibilidade de alternativas para o tratamento do tumor podem restringir o mercado. A presença de um grande número de produtos em pipelines, juntamente com iniciativas estratégicas tomadas pelos participantes do mercado, estão a funcionar como uma oportunidade para o mercado. A falta de profissionais qualificados pode ser um desafio para o mercado.
O relatório global do mercado de fabrico de células estaminais fornece detalhes de quota de mercado, novos desenvolvimentos e impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para obter um Analyst Brief. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.
Âmbito do mercado global de fabrico de células estaminais e tamanho do mercado
O mercado de fabrico de células estaminais da Ásia-Pacífico está categorizado em quatro segmentos notáveis que se baseiam em produtos, aplicação, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base nos produtos, o mercado de fabrico de células estaminais está segmentado em linhas de células estaminais, instrumentos, consumíveis e kits. Em 2021, prevê-se que o segmento dos consumíveis e kits domine o mercado devido à compra frequente de consumíveis, ao aumento da investigação com células estaminais e ao aumento da procura de terapias com células estaminais.
- Com base na aplicação, o mercado de fabrico de células estaminais está segmentado em aplicações de investigação, aplicações clínicas, bancos de células e tecidos e outros. Em 2021, prevê-se que o segmento das aplicações de investigação domine o mercado devido ao crescente foco na investigação de citologia e fisiopatologia das células estaminais e ao crescente financiamento público-privado para apoiar o desenvolvimento e comercialização de produtos com células estaminais.
- Com base no utilizador final, o mercado de fabrico de células estaminais está segmentado em empresas de biotecnologia e farmacêuticas, institutos de investigação e institutos académicos, bancos de células e bancos de tecidos, hospitais e centros cirúrgicos e outros. Em 2021, prevê-se que o segmento das empresas farmacêuticas e de biotecnologia domine o mercado devido à crescente ênfase em iniciativas estratégicas (como aquisições, parcerias e colaborações) por parte das empresas farmacêuticas e de biotecnologia para expandir as suas capacidades na investigação com células estaminais.
- Com base no canal de distribuição, o mercado de fabrico de células estaminais está segmentado em vendas diretas e distribuidores externos. Em 2021, prevê-se que o segmento de vendas diretas domine o mercado devido ao grande número de players no mercado.
Análise a nível de país do mercado de fabrico de células estaminais da Ásia-Pacífico
O mercado de fabrico de células estaminais é analisado e as informações sobre o tamanho do mercado são fornecidas por produtos, aplicação, utilizador final e canal de distribuição.
Os países abrangidos no relatório do Mercado de Fabrico de Células Estaminais são a China, Japão, Índia, Austrália, Coreia do Sul, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, resto da Ásia-Pacífico (APAC).
China is dominating the global stem cell manufacturing maket in the Asia Pacific region due to increased awareness regarding the stem cell based treatment and advanced technology adoption.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Global Stem Cell Manufacturing Market
The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.
Competitive Landscape and Stem Cell Manufacturing Market Share Analysis
The stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.
The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.
The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.
For instance,
- In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
- Em junho de 2021, a Catalent Inc. anunciou que adquiriu a RheinCell Therapeuics, que é fabricante de células estaminais pluripotentes induzidas por humanos. Isto ajudará a empresa a desenvolver o processo de desenvolvimento de terapia celular personalizado existente.
- Em junho de 2021, a Bio-Techne anunciou que tinha melhorado a sua capacidade de engenharia genética e de fabrico de terapia celular e genética. Isto ajudará a empresa a expandir ainda mais o seu negócio.
A colaboração, as joint ventures e outras estratégias do player de mercado estão a melhorar o mercado da empresa no mercado de fabrico de células estaminais, o que também oferece o benefício para a organização melhorar a sua oferta para o mercado de fabrico de células estaminais.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: REGULATIONS
5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
5.2 REGULATORY FRAMEWORK IN EUROPE
5.3 REGULATORY FRAMEWORK IN INDIA
5.4 REGULATORY FRAMEWORK IN JAPAN
6 PESTEL ANALYSIS
7 PORTERS FIVE FORCES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CANCER
8.1.2 INCREASE INVESTMENT IN R & D
8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
8.2 RESTRAINTS
8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
8.3 OPPORTUNITIES
8.3.1 PRESENCE OF PIPELINE PRODUCTS
8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 IMPACT OF COVID-19 ON ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY
9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
9.5 CONCLUSION
10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 CONSUMABLES & KITS
10.2.1 CULTURE MEDIA
10.2.2 DIFFERENTIATION KITS
10.2.3 STEM CELL ANTIBODY ARRAYS
10.2.4 IDENTIFICATION KITS
10.2.5 STEM CELL ANTIBODY PANELS
10.2.6 STEM CELL PRIMER PAIR PANELS
10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
10.2.9 OTHERS
10.3 STEM CELL LINES
10.3.1 HUMAN CELL SYSTEMS
10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
10.3.1.2 MESENCHYMAL STEM CELLS
10.3.1.3 PRIMARY HUMAN CELLS
10.3.1.3.1 FIBROBLAST
10.3.1.3.2 EPITHELIAL
10.3.1.3.3 ENDOTHELIAL
10.3.1.4 HEMATOPOIETIC STEM CELLS
10.3.1.5 NEURAL STEM CELLS
10.3.1.6 CARDIAC STEM CELLS
10.3.1.7 PANCREATIC STEM CELLS
10.3.1.8 OTHERS
10.3.2 RODENT CELL SYSTEMS
10.3.2.1 PLURIPOTENT MOUSE ES CELLS
10.3.2.2 MOUSE EMBRYO CULTURE
10.3.2.3 PMEFS
10.3.2.4 MULTIPOTENT RODENT STEM CELLS
10.3.2.5 MESENCHYMAL STEM CELLS
10.3.2.6 NEURAL STEM CELLS
10.3.2.7 OTHERS
10.4 INSTRUMENTS
10.4.1 BIOREACTORS & INCUBATORS
10.4.2 CELL SORTERS
10.4.3 OTHERS
11 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 RESEARCH APPLICATIONS
11.2.1 LIFE SCIENCE RESEARCH
11.2.2 DRUG DISCOVERY AND DEVELOPMENT
11.3 CLINICAL APPLICATIONS
11.3.1 ALLOGENIC STEM CELL THERAPY
11.3.1.1 SURGERIES
11.3.1.2 MUSCULOSKELETAL DISORDERS
11.3.1.3 WOUNDS AND INJURIES
11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
11.3.1.5 OTHERS
11.3.2 AUTOLOGOUS STEM CELL THERAPY
11.3.2.1 WOUNDS & INJURIES
11.3.2.2 CARDIOVASCULAR DISEASES
11.3.2.3 GASTROINTESTINAL DISEASES
11.3.2.4 OTHERS
11.4 CELL & TISSUE BANKING
11.5 OTHERS
12 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER
12.1 OVERVIEW
12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
12.4 CELL BANKS & TISSUE BANKS
12.5 HOSPITALS & SURGICAL CENTERS
12.6 OTHERS
13 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT SALES
13.3 THIRD PARTY DISTRIBUTORS
14 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY REGION
14.1 OVERVIEW
14.2 ASIA-PACIFIC
14.2.1 CHINA
14.2.2 JAPAN
14.2.3 SOUTH KOREA
14.2.4 AUSTRALIA
14.2.5 SINGAPORE
14.2.6 INDIA
14.2.7 THAILAND
14.2.8 MALAYSIA
14.2.9 INDONESIA
14.2.10 PHILIPPINES
14.2.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 AMERICAN CRYOSYSTEM CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 ANTEROGEN.CO.,LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ASTELLAS PHARMA INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 BD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 COMPANY SHARE ANALYSIS
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENT
17.8 BIO-TECHNE
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 CATALENT, INC
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 DAIICHI SANKYO COMPANY, LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 FUJIFILM CELLULAR DYNAMICS, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 COMPANY SHARE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 MESOBLAST LTD
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENT
17.13 ORGANOGENESIS INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 PROMOCELL GMBH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 REPROCELL INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SARTORIUS AG
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 STEMCELL TECHNOLOGIES INC.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 VERICEL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 VIACYTE, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 VISTAGEN THERAPEUTICS, INC.
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:
TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 1 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 17 CHINA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 18 CHINA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 19 CHINA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 20 CHINA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 21 CHINA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 22 CHINA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 23 CHINA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 24 CHINA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 CHINA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 CHINA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 27 CHINA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 28 CHINA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 29 CHINA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 CHINA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 JAPAN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 32 JAPAN CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 JAPAN STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 JAPAN HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 JAPAN PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 JAPAN RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 37 JAPAN INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 38 JAPAN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 JAPAN RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 JAPAN CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 JAPAN ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 JAPAN AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 JAPAN STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 JAPAN STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 46 SOUTH KOREA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 47 SOUTH KOREA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 48 SOUTH KOREA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 49 SOUTH KOREA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 50 SOUTH KOREA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 51 SOUTH KOREA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 52 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 SOUTH KOREA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 SOUTH KOREA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 SOUTH KOREA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 SOUTH KOREA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 SOUTH KOREA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 59 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 60 AUSTRALIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 61 AUSTRALIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 62 AUSTRALIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 63 AUSTRALIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 64 AUSTRALIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 65 AUSTRALIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 66 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 AUSTRALIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 AUSTRALIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 AUSTRALIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 AUSTRALIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 71 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 AUSTRALIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 73 SINGAPORE STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 74 SINGAPORE CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 75 SINGAPORE STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 76 SINGAPORE HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 77 SINGAPORE PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 78 SINGAPORE RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 79 SINGAPORE INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 80 SINGAPORE STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 SINGAPORE RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 SINGAPORE CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 SINGAPORE ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 SINGAPORE AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 SINGAPORE STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 SINGAPORE STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 INDIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 88 INDIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 89 INDIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 90 INDIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 91 INDIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 92 INDIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 93 INDIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 94 INDIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 95 INDIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 96 INDIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 INDIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 INDIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 INDIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 INDIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 THAILAND STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 102 THAILAND CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 103 THAILAND STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 104 THAILAND HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 105 THAILAND PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 106 THAILAND RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 107 THAILAND INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 108 THAILAND STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 THAILAND RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 THAILAND ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 THAILAND AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 THAILAND STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 THAILAND STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 119 MALAYSIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 120 MALAYSIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 121 MALAYSIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 122 MALAYSIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 MALAYSIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 124 MALAYSIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 125 MALAYSIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 126 MALAYSIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 MALAYSIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 128 MALAYSIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 129 INDONESIA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 130 INDONESIA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 131 INDONESIA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 132 INDONESIA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 133 INDONESIA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 134 INDONESIA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 135 INDONESIA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 136 INDONESIA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 137 INDONESIA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 138 INDONESIA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 139 INDONESIA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 140 INDONESIA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 141 INDONESIA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 142 INDONESIA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 143 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 144 PHILIPPINES CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 145 PHILIPPINES STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 146 PHILIPPINES HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 147 PHILIPPINES PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 148 PHILIPPINES RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 149 PHILIPPINES INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 150 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 151 PHILIPPINES RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 152 PHILIPPINES CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 153 PHILIPPINES ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 154 PHILIPPINES AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 155 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 156 PHILIPPINES STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 157 REST OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE ASIA-PACIFIC STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC STEM CELL MANUFACTURING MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC STEM CELL MANUFACTURING MARKET
FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
FIGURE 15 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
FIGURE 16 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
FIGURE 17 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
FIGURE 18 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 19 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
FIGURE 20 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
FIGURE 21 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY END USER, 2020
FIGURE 24 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
FIGURE 25 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
FIGURE 26 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
FIGURE 28 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
FIGURE 29 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 30 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 32 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2020)
FIGURE 33 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2021 & 2028)
FIGURE 34 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY REGION (2020 & 2028)
FIGURE 35 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 36 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
FIGURE 37 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
FIGURE 38 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 39 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 40 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
FIGURE 41 ASIA-PACIFIC STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
